Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.68 |
| ▸ | HTR2A | P28223 | 6/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.50 |
| ▸ | HTR2C | P28335 | 3/20 | 0.50 |
| ▸ | HTR2B | P41595 | 3/20 | 0.50 |
| ▸ | PAM | P19021 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 1/20 | 0.48 |
| ▸ | DRD2 | P14416 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7514298 | 1.00 | IDO1 (0.68) | IDO1HTR2ASIGMAR1HTR2CHTR2B | |
| SCHEMBL430934 | 1.00 | IDO1 (0.68) | IDO1HTR2ASIGMAR1HTR2CHTR2B | |
| SCHEMBL7254873 | 0.91 | IDO1 (0.63) | IDO1HTR2ASIGMAR1HTR2CHTR2B | |
| SCHEMBL7254870 | 0.91 | IDO1 (0.63) | IDO1HTR2ASIGMAR1HTR2CHTR2B | |
| SCHEMBL20127256 | 0.91 | IDO1 (0.63) | IDO1HTR2ASIGMAR1HTR2CHTR2B | |
| Catechol SCHEMBL10615010 | 0.89 | IDO1 (0.57) | IDO1HTR2ASIGMAR1HTR2CHTR2B | |
| SCHEMBL1158122 | 0.89 | IDO1 (0.57) | IDO1HTR2ASIGMAR1HTR2CHTR2B | |
| Catechol SCHEMBL10615001 | 0.89 | IDO1 (0.57) | IDO1HTR2ASIGMAR1HTR2CHTR2B | |
| SCHEMBL1158123 | 0.89 | IDO1 (0.57) | IDO1HTR2ASIGMAR1HTR2CHTR2B | |
| SCHEMBL10624030 | 0.89 | IDO1 (0.62) | IDO1HTR2ASIGMAR1HTR2CHTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024119101-A1 | STIMULI-RESPONSIVE TRACELESS ENGINEERING PLATFORM FOR INTRACELLULAR PAYLOAD DELIVERY | YALE UNIVERSITY (US) | 2024-06-06 | — | — | WO | claimed |
| CN-112920119-B | Preparation method of aporphine alkaloid | 中国药科大学 | 2023-05-23 | — | — | CN | claimed |
| US-8557262-B2 | Divinyl ether derivatives capable of releasing active aldehydes and ketones and methods of use for perfuming surfaces | FIRMENICH SA (CH) | 2013-10-15 | — | — | US | claimed |
| US-8308892-B2 | Di-cinnamyl compounds and methods for use thereof | DESIGNER MOLECULES, INC. (US) | 2012-11-13 | — | — | US | claimed |
| EP-2334626-A1 | DIVINYL ETHER DERIVATIVES CAPABLE OF RELEASING ACTIVE ALDEHYDES AND KETONES AND METHODS OF USE FOR PERFUMING SURFACES | Firmenich S.A. (CH) | 2011-06-22 | — | — | EP | claimed |
| US-20110142776-A1 | DIVINYL ETHER DERIVATIVES CAPABLE OF RELEASING ACTIVE ALDEHYDES AND KETONES AND METHODS OF USE FOR PERFUMING SURFACES | FIRMENICH SA (CH) | 2011-06-16 | — | — | US | claimed |
| WO-2010029462-A1 | DIVINYL ETHER DERIVATIVES CAPABLE OF RELEASING ACTIVE ALDEHYDES AND KETONES AND METHODS OF USE FOR PERFUMING SURFACES | FIRMENICH SA (CH) | 2010-03-18 | — | — | WO | claimed |
| US-20090288768-A1 | DI-CINNAMYL COMPOUNDS AND METHODS FOR USE THEREOF | DESIGNER MOLECULES, INC. | 2009-11-26 | — | — | US | claimed |
| US-20090143626-A1 | PROCESS FOR PREPARING AN ARYLALKYL COMPOUND | SHELL OIL COMPANY | 2009-06-04 | — | — | US | claimed |
| WO-2009021866-A1 | PROCESS FOR PREPARING AN ARYLALKYL COMPOUND | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2009-02-19 | — | — | WO | claimed |
| US-6939595-B2 | Magnetic recording medium substrate using thermoplastic allyloxymethylstyrene resin, magnetic recording medium using the substrate, and method of manufacturing the magnetic recording medium | FUJI ELECTRIC DEVICE TECHNOLOGY CO., LTD. (JP) | 2005-09-06 | — | — | US | claimed |
| US-20040151948-A1 | Magnetic recording medium substrate using thermoplastic allyloxymethylstyrene resin, magnetic recording medium using the substrate, and method of manufacturing the magnetic recording medium | FUJI ELECTRIC CO., LTD. (JP) | 2004-08-05 | — | — | US | claimed |
| US-20260068882-A1 | ARTHROPOD CONTROLLING COMPOSITION | FIRMENICH & CIE (CH) | 2026-03-12 | — | — | US | disclosed |
| CN-121591684-A | Regulation and control method for catalyzing transfer hydrogenation and etherification of biomass-based aldehydes | 岭南师范学院 | 2026-03-03 | — | — | CN | disclosed |
| US-RE50800-E1 | Pro-fragrance compounds | FIRMENICH SA (CH) | 2026-02-17 | — | — | US | disclosed |
| EP-4604951-A1 | 1-(SULFONYL)-N-PHENYLPYRROLIDINE-2-CARBOXAMIDES DERIVATIVES AND USE THEREOF | AMIRA THERAPEUTICS, S.L. (ES) | 2025-08-27 | — | — | EP | disclosed |
| US-4778864-A | COATINGS WITH FREE RADICAL POLYMERIZABLE COMPOUNDS AND ALLYLOXY COMPOUNDS; LONG POT LIFE | MONSANTO COMPANY (US) | 1988-10-18 | — | — | US | disclosed |
| EP-0273025-A2 | Stabilized metal drier | MONSANTO COMPANY (US) | 1988-06-29 | — | — | EP | disclosed |
| US-4670308-A | FREE RADICAL POLYMERIZATION | MONSANTO COMPANY (US) | 1987-06-02 | — | — | US | disclosed |
| EP-0210158-A1 | Surface coating process | Monsanto Company (US) | 1987-01-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260068882-A1 | ARTHROPOD CONTROLLING COMPOSITION | CNOT9, MSL1, MT-CO2 | IDO1 638/4885HTR2A 2456/4885SIGMAR1 1863/4885 |
| US-20110142776-A1 | DIVINYL ETHER DERIVATIVES CAPABLE OF RELEASING ACTIVE ALDEHYDES AND KETONES AND METHODS OF USE FOR PERFUMING SURFACES | DBN1, DECR2, DECR1 | IDO1 2274/4885HTR2A 257/4885SIGMAR1 807/4885 |
| US-20090288768-A1 | DI-CINNAMYL COMPOUNDS AND METHODS FOR USE THEREOF | CAD, DBF4, ACMSD | IDO1 2736/4885HTR2A 4135/4885SIGMAR1 4142/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.